MedTrace Logo

SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis

NCT06047964 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 281

Last updated 2024-10-21

No results posted yet for this study

Summary

This study is aiming to evaluate the safety and efficacy of SeQuent® Please CIS in the endovascular treatment of symptomatic intracranial atherosclerotic stenosis and restenosis after interventional therapy.

Conditions

  • Stroke
  • Intracranial Atherosclerotic Stenosis

Interventions

DEVICE

DCB

Intracranial paclitaxel drug-eluting balloon catheters (SeQuent® Please CIS)

DEVICE

POBA

Intracranial PTA balloon catheter

Sponsors & Collaborators

  • B. Braun Medical International Trading Company Ltd.

    lead INDUSTRY

Principal Investigators

  • Liqun Jiao, MD · Xuanwu Hospital, Beijing

  • Yan Ma, MD · Xuanwu Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-23
Primary Completion
2024-09-29
Completion
2025-01-23

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06047964 on ClinicalTrials.gov